A Primer: Solving the Unique Problems of Orphan Drug Communications Programs
Posted: January 7, 2014
By: LaVoie Group
This paper outlines the considerations that must be taken into account when planning orphan disease drug communication programs and the best practice approaches to implementing them successfully through pre-approval, approval and post-approval phases.
Challenges can be met and opportunities realized with carefully planned and intelligently integrated communications programs that focus on best practices and solutions that balance the diverse needs by using experience, key learnings from mistakes as well as successes.
Share this content with your network.
By clicking this 'Download Now' box, you consent to BioCentury forwarding your information
to the company that wrote this White Paper and you agree that said company can use